The abstract is read at the publisher; the summary is JClub's.
EBF1 marks a novel disease-associated arterial endothelial subpopulation that emerges during pulmonary hypertension progression in Sugen5416/hypoxia rats and is linked to human PAH.
- Why it matters: PAH has limited palliative options, and the field lacks molecular regulators tied to distinct disease-stage endothelial populations.
- What they did: The team built single-cell multiome maps at four time points in rat pulmonary hypertension, reanalyzed human PAH single-cell RNA-seq for conservation, then used in silico simulations and pulmonary endothelium-targeting viral Ebf1 knockdown.
- The result: Ebf1 knockdown ameliorated PH pathological hallmarks, including right ventricular systolic pressure and right ventricular hypertrophy, when delivered before or after disease onset, supporting EBF1 as a therapeutic target.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.